Last 12 months
Inside the activity.
0 purchase rows · 73 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 42 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 18 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 07, 2020 Filed Feb 12, 2020 23:23 UTC Amendment |
SANO KUNIOPresident of Aehr Test Japan
|
Exercise / conversionIncentive stock option (right to buy) · Derivative | 2,000 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001654954-20-001404 · section16.xml · derivative · entry 3 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 2,000 shares Expires 2020-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: This report on Form 4/A is being filed to correct the Price of Derivative Security as previously reported in Column 8 of Table II. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| February 07, 2020 Filed Feb 12, 2020 23:23 UTC Amendment |
SANO KUNIOPresident of Aehr Test Japan
|
SaleCommon Stock | 2,000 | $2.02 | $4,040.00 |
DisclosureSEC source: 0001654954-20-001404 · section16.xml · nonDerivative · entry 2 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 07, 2020 Filed Feb 12, 2020 23:23 UTC Amendment |
SANO KUNIOPresident of Aehr Test Japan
|
Exercise / conversionCommon Stock | 2,000 | $1.28 | $2,560.00 |
DisclosureSEC source: 0001654954-20-001404 · section16.xml · nonDerivative · entry 1 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 01:36 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $1.28 | $0.00 |
DisclosureSEC source: 0001654954-20-000904 · section16.xml · derivative · entry 5 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 3,000 shares Expires 2020-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 01:36 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
SaleCommon Stock | 1,000 | $2.10 | $2,100.00 |
DisclosureSEC source: 0001654954-20-000904 · section16.xml · nonDerivative · entry 4 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 01:36 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
SaleCommon Stock | 1,000 | $2.05 | $2,052.00 |
DisclosureSEC source: 0001654954-20-000904 · section16.xml · nonDerivative · entry 3 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 01:36 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
SaleCommon Stock | 1,000 | $2.00 | $2,000.00 |
DisclosureSEC source: 0001654954-20-000904 · section16.xml · nonDerivative · entry 2 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| January 28, 2020 Filed Jan 30, 2020 01:36 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
Exercise / conversionCommon Stock | 3,000 | $1.28 | $3,840.00 |
DisclosureSEC source: 0001654954-20-000904 · section16.xml · nonDerivative · entry 1 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 14, 2020 Filed Jan 15, 2020 01:36 UTC |
Erickson GaynDirector · President and CEO
|
SaleCommon Stock | 500 | $1.86 | $930.00 |
DisclosureSEC source: 0001654954-20-000448 · section16.xml · nonDerivative · entry 4 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,015 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. Read SEC document |
| January 14, 2020 Filed Jan 15, 2020 01:36 UTC |
Erickson GaynDirector · President and CEO
|
SaleCommon Stock | 1,500 | $1.88 | $2,812.50 |
DisclosureSEC source: 0001654954-20-000448 · section16.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,515 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. Read SEC document |
| January 14, 2020 Filed Jan 15, 2020 01:36 UTC |
Erickson GaynDirector · President and CEO
|
SaleCommon Stock | 500 | $1.85 | $926.10 |
DisclosureSEC source: 0001654954-20-000448 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,015 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. Read SEC document |
| January 14, 2020 Filed Jan 15, 2020 01:36 UTC |
Erickson GaynDirector · President and CEO
|
SaleCommon Stock | 17,500 | $1.81 | $31,605.00 |
DisclosureSEC source: 0001654954-20-000448 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,515 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. Read SEC document |
| November 12, 2019 Filed Nov 13, 2019 01:24 UTC |
FUCCI DAVIDVP of Operations
|
SaleCommon Stock | 2,186 | $2.01 | $4,394.08 |
DisclosureSEC source: 0001654954-19-012762 · section16.xml · nonDerivative · entry 1 FUCCI DAVID · CIK 0001609842 · VP of Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,581 Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 00:09 UTC |
ROSATI MARIO MDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001654954-19-011958 · section16.xml · derivative · entry 1 ROSATI MARIO M · CIK 0001197808 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2026-10-22 F1 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| October 22, 2019 Filed Oct 23, 2019 23:09 UTC |
POSEDEL RHEA JDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001654954-19-011956 · section16.xml · derivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2026-10-22 F1 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 01:54 UTC |
OLIPHANT LAURADirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001654954-19-011964 · section16.xml · derivative · entry 1 OLIPHANT LAURA · CIK 0001783244 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2026-10-22 F1 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 01:38 UTC |
SLAYEN HOWARD TDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001654954-19-011962 · section16.xml · derivative · entry 1 SLAYEN HOWARD T · CIK 0001203324 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2026-10-22 F1 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 00:52 UTC |
Schneider John M.Director
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001654954-19-011960 · section16.xml · derivative · entry 1 Schneider John M. · CIK 0001625605 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2026-10-22 F1 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| October 08, 2019 Filed Oct 9, 2019 01:32 UTC |
ROSATI MARIO MDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.97 | $0.00 |
DisclosureSEC source: 0001654954-19-011557 · section16.xml · derivative · entry 9 ROSATI MARIO M · CIK 0001197808 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 2,500 shares became exercisable on this date and an additional one ninth (1/9) of 7,500 shares became exercisable each month thereafter. Read SEC document |
| October 08, 2019 Filed Oct 9, 2019 01:32 UTC |
ROSATI MARIO MDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 31,918 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001654954-19-011557 · section16.xml · derivative · entry 8 ROSATI MARIO M · CIK 0001197808 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,918 shares Expires 2019-11-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One sixth (1/6) of the total number of shares became exercisable on this date and an additional one sixth (1/6) of the total number of shares became exercisable each month thereafter. Read SEC document |
| October 08, 2019 Filed Oct 9, 2019 01:32 UTC |
ROSATI MARIO MDirector
|
SaleCommon Stock | 41,918 | $1.67 | $70,208.46 |
DisclosureSEC source: 0001654954-19-011557 · section16.xml · nonDerivative · entry 3 ROSATI MARIO M · CIK 0001197808 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,701 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.65 to $1.77, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| October 08, 2019 Filed Oct 9, 2019 01:32 UTC |
ROSATI MARIO MDirector
|
Exercise / conversionCommon Stock | 10,000 | $0.97 | $9,700.00 |
DisclosureSEC source: 0001654954-19-011557 · section16.xml · nonDerivative · entry 2 ROSATI MARIO M · CIK 0001197808 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 08, 2019 Filed Oct 9, 2019 01:32 UTC |
ROSATI MARIO MDirector
|
Exercise / conversionCommon Stock | 31,918 | $0.80 | $25,534.40 |
DisclosureSEC source: 0001654954-19-011557 · section16.xml · nonDerivative · entry 1 ROSATI MARIO M · CIK 0001197808 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 04, 2019 Filed Oct 7, 2019 22:15 UTC |
Erickson GaynDirector · President and CEO
|
SaleCommon stock | 17,322 | $1.61 | $27,888.42 |
DisclosureSEC source: 0001654954-19-011516 · section16.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 514,015 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. Read SEC document |
| October 03, 2019 Filed Oct 7, 2019 22:15 UTC |
Erickson GaynDirector · President and CEO
|
SaleCommon stock | 2,678 | $1.69 | $4,523.68 |
DisclosureSEC source: 0001654954-19-011516 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,337 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 00:23 UTC |
SPINK KENNETH B.VP of Finance and CFO
|
OtherCommon Stock | 3,000 | $1.14 | $3,417.00 |
DisclosureSEC source: 0001654954-19-011387 · section16.xml · nonDerivative · entry 1 SPINK KENNETH B. · CIK 0001652627 · VP of Finance and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,287 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 00:23 UTC |
RICHMOND DONALD P. IIVP of Engineering
|
OtherCommon Stock | 3,000 | $1.14 | $3,417.00 |
DisclosureSEC source: 0001654954-19-011388 · section16.xml · nonDerivative · entry 1 RICHMOND DONALD P. II · CIK 0001736207 · VP of Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,506 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 00:14 UTC |
Erickson GaynDirector · President and CEO
|
OtherCommon Stock | 3,000 | $1.14 | $3,417.00 |
DisclosureSEC source: 0001654954-19-011384 · section16.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534,015 F1 · shares: These shares have been purchased through the Company's Amended and Restated 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
| July 23, 2019 Filed Jul 23, 2019 22:38 UTC |
Erickson GaynDirector · President & CEO
|
SaleCommon Stock | 40,000 | $1.42 | $56,880.00 |
DisclosureSEC source: 0001040470-19-000017 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 531,015 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.42 to $1.471, inclusive. The reporting person undertakes to provide to Aehr Test Systems, any security holder of Aehr Test Systems, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above. Read SEC document |
| July 16, 2019 Filed Jul 19, 2019 01:47 UTC |
POSEDEL RHEA JDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001040470-19-000015 · primary_doc.xml · derivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2026-07-16 F1 · derivative.exercise_date: One twelfth (1/12) of the total number of shares became exercisable on this date and an additional one twelfth (1/12) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 16, 2019 Filed Jul 19, 2019 01:16 UTC |
ROGERS VERNONEXE. VP OF SALES & MARKETING
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 24,738 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001040470-19-000014 · primary_doc.xml · derivative · entry 2 ROGERS VERNON · CIK 0001756642 · EXE. VP OF SALES & MARKETING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,738 Underlying: Common Stock · 24,738 shares Expires 2026-07-16 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 16, 2019 Filed Jul 19, 2019 01:16 UTC |
ROGERS VERNONEXE. VP OF SALES & MARKETING
|
GrantIncentive Stock Option (right to buy) · Derivative | 15,262 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001040470-19-000014 · primary_doc.xml · derivative · entry 1 ROGERS VERNON · CIK 0001756642 · EXE. VP OF SALES & MARKETING 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,262 Underlying: Common Stock · 15,262 shares Expires 2019-06-26 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 16, 2019 Filed Jul 19, 2019 01:00 UTC |
RICHMOND DONALD P. IIVP of Engineering
|
GrantIncentive Stock Option (right to buy) · Derivative | 34,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001040470-19-000013 · primary_doc.xml · derivative · entry 1 RICHMOND DONALD P. II · CIK 0001736207 · VP of Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,000 Underlying: Common Stock · 34,000 shares Expires 2026-07-16 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 16, 2019 Filed Jul 19, 2019 00:51 UTC |
HENDRICKSON DAVID SCHIEF TECHNOLOGY OFFICER
|
GrantIncentive Stock Option (right to buy) · Derivative | 23,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001040470-19-000012 · primary_doc.xml · derivative · entry 1 HENDRICKSON DAVID S · CIK 0001244094 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2026-07-16 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 16, 2019 Filed Jul 19, 2019 00:38 UTC |
FUCCI DAVIDVP OF OPERATIONS
|
GrantIncentive Stock Option (right to buy) · Derivative | 23,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001040470-19-000011 · primary_doc.xml · derivative · entry 1 FUCCI DAVID · CIK 0001609842 · VP OF OPERATIONS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2026-07-16 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 16, 2019 Filed Jul 19, 2019 00:29 UTC |
SPINK KENNETH B.VP OF FINANCE & CFO
|
GrantIncentive Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001040470-19-000010 · primary_doc.xml · derivative · entry 1 SPINK KENNETH B. · CIK 0001652627 · VP OF FINANCE & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2026-07-16 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 16, 2019 Filed Jul 19, 2019 00:14 UTC |
Erickson GaynDirector · President & CEO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 66,065 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001040470-19-000009 · primary_doc.xml · derivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,065 Underlying: Common Stock · 66,065 shares Expires 2026-07-16 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 16, 2019 Filed Jul 19, 2019 00:14 UTC |
Erickson GaynDirector · President & CEO
|
GrantIncentive Stock Option (right to buy) · Derivative | 63,935 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001040470-19-000009 · primary_doc.xml · derivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,935 Underlying: Common Stock · 63,935 shares Expires 2026-07-16 F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 16, 2019 Filed Jul 27, 2019 00:00 UTC Amendment |
POSEDEL RHEA JDirector
|
OtherNon-Qualified Stock Option(right to buy) · Derivative | 0 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001040470-19-000018 · primary_doc.xml · derivative · entry 1 POSEDEL RHEA J · CIK 0001055117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 0 shares Expires not disclosed F1 · kind: On July 18, 2019, the Reporting Person mistakenly filed a Form 4 reporting the grant of a non-qualified stock option to purchase 18,000 shares of Common Stock, which stock option was not granted. F1 · derivative.exercise_date: On July 18, 2019, the Reporting Person mistakenly filed a Form 4 reporting the grant of a non-qualified stock option to purchase 18,000 shares of Common Stock, which stock option was not granted. F1 · derivative.expiration_date: On July 18, 2019, the Reporting Person mistakenly filed a Form 4 reporting the grant of a non-qualified stock option to purchase 18,000 shares of Common Stock, which stock option was not granted. Read SEC document |
| May 17, 2019 Filed May 17, 2019 22:12 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001040470-19-000008 · primary_doc.xml · derivative · entry 6 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2019-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| May 17, 2019 Filed May 17, 2019 22:12 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
SaleCommon Stock | 5,000 | $1.56 | $7,777.00 |
DisclosureSEC source: 0001040470-19-000008 · primary_doc.xml · nonDerivative · entry 5 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| May 17, 2019 Filed May 17, 2019 22:12 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
SaleCommon Stock | 5,000 | $1.56 | $7,776.00 |
DisclosureSEC source: 0001040470-19-000008 · primary_doc.xml · nonDerivative · entry 4 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| May 17, 2019 Filed May 17, 2019 22:12 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
SaleCommon Stock | 5,000 | $1.56 | $7,775.00 |
DisclosureSEC source: 0001040470-19-000008 · primary_doc.xml · nonDerivative · entry 3 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| May 17, 2019 Filed May 17, 2019 22:12 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
SaleCommon Stock | 5,000 | $1.56 | $7,776.50 |
DisclosureSEC source: 0001040470-19-000008 · primary_doc.xml · nonDerivative · entry 2 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| May 17, 2019 Filed May 17, 2019 22:12 UTC |
SANO KUNIOPresident of Aehr Test Japan
|
Exercise / conversionCommon Stock | 20,000 | $1.27 | $25,420.00 |
DisclosureSEC source: 0001040470-19-000008 · primary_doc.xml · nonDerivative · entry 1 SANO KUNIO · CIK 0001254638 · President of Aehr Test Japan 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2019 Filed May 1, 2019 00:35 UTC |
BUCK CARL NFormer VP of Marketing
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 4,698 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001040470-19-000007 · primary_doc.xml · derivative · entry 7 BUCK CARL N · CIK 0001243930 · Former VP of Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 4,698 shares Expires 2019-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| April 30, 2019 Filed May 1, 2019 00:35 UTC |
BUCK CARL NFormer VP of Marketing
|
SaleCommon Stock | 4,698 | $1.65 | $7,751.70 |
DisclosureSEC source: 0001040470-19-000007 · primary_doc.xml · nonDerivative · entry 4 BUCK CARL N · CIK 0001243930 · Former VP of Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| April 30, 2019 Filed May 1, 2019 00:35 UTC |
BUCK CARL NFormer VP of Marketing
|
Exercise / conversionCommon Stock | 4,698 | $1.27 | $5,971.16 |
DisclosureSEC source: 0001040470-19-000007 · primary_doc.xml · nonDerivative · entry 3 BUCK CARL N · CIK 0001243930 · Former VP of Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2019 Filed May 1, 2019 00:35 UTC |
BUCK CARL NFormer VP of Marketing
|
Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 100 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001040470-19-000007 · primary_doc.xml · derivative · entry 6 BUCK CARL N · CIK 0001243930 · Former VP of Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,698 Underlying: Common Stock · 100 shares Expires 2019-06-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| April 29, 2019 Filed May 1, 2019 00:35 UTC |
BUCK CARL NFormer VP of Marketing
|
SaleCommon Stock | 100 | $1.65 | $165.00 |
DisclosureSEC source: 0001040470-19-000007 · primary_doc.xml · nonDerivative · entry 2 BUCK CARL N · CIK 0001243930 · Former VP of Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.